Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-079781

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul N Clark
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareNov 9, 2015P11,646$0.75A1,032,324IBy Trust
Common Stock, par value $0.001 per shareNov 9, 2015P7,000$0.76A1,039,324IBy Trust
Common Stock, par value $0.001 per shareNov 9, 2015P2,800$0.77A1,042,124IBy Trust
Common Stock, par value $0.001 per shareNov 9, 2015P2,923$0.78A1,045,047IBy Trust
Common Stock, par value $0.001 per shareNov 9, 2015P10,210$0.79A1,055,257IBy Trust
Common Stock, par value $0.001 per shareNov 10, 2015P4,300$0.73A1,059,557IBy Trust
Common Stock, par value $0.001 per shareNov 10, 2015P39,699$0.74A1,099,256IBy Trust
Common Stock, par value $0.001 per shareNov 10, 2015P23,501$0.75A1,122,757IBy Trust
Common Stock, par value $0.001 per shareNov 10, 2015P32,500$0.76A1,155,257IBy Trust

Table II — derivative securities

No Table II lines on this filing.